Radcliffe Capital Management’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Radcliffe Capital Management’s Portfolio AFTR Stock Details AFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-792,615	Closed	-$8.21M	–	555
2023 Q2	$8.21M	Sell	792,615 -1,080	-0.1%	-$11.1K	0.7%	26
2023 Q1	$8.11M	Hold	793,695	–	–	0.51%	43
2022 Q4	$7.95M	Buy	793,695 +103,487	+15%	+$1.03M	0.25%	83
2022 Q3	$6.75M	Hold	690,208	–	–	0.16%	162
2022 Q2	$6.7M	Buy	690,208 +432,210	+168%	+$4.19M	0.15%	155
2022 Q1	$2.5M	Buy	+257,998	New	+$2.49M	0.06%	535

Radcliffe Capital Management's AFTR Position: Q3 2023 in Review

Radcliffe Capital Management sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q3 2023, closing a stake of 792,615 shares — an estimated $8.21M sold.

Radcliffe Capital Management first reported a position in AFTR in Q1 2022 and held it in 6 quarters. The position peaked at $8.21M in Q2 2023. 0 funds tracked by Wall St. Rank hold AFTR as of Q3 2023.

Radcliffe Capital Management reported no remaining AfterNext HealthTech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
Radcliffe Capital Management sold 792,615 AfterNext HealthTech Acquisition Corp shares in Q3 2023, an estimated $8.21M.
Radcliffe Capital Management first reported a position in AfterNext HealthTech Acquisition Corp in Q1 2022 and held it in 6 quarters.
Radcliffe Capital Management's AfterNext HealthTech Acquisition Corp position peaked at $8.21M in Q2 2023.
0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.